Mounjaro approved to reduce cardiovascular events in adults with diabetes

morningstar.com·Aug 28, 2026 · 1 g fa

FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

time.com·Aug 28, 2026 · 1 g fa

Mounjaro Is Now Approved to Lower the Risk of Heart Events

qz.com·Aug 28, 2026 · 1 g fa

FDA approves Mounjaro to lower heart attack and stroke risk

independent.co.uk·Aug 28, 2026 · 1 g fa

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks

independent.co.uk·Aug 28, 2026 · 1 g fa

Weight-loss drugs could help treat other health conditions. Here’s what could be next

endpoints.news·Aug 28, 2026 · 1 g fa

Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug

valor.globo.com·Aug 28, 2026 · 1 g fa

Regulador dos EUA aprova Mounjaro, da Eli Lilly, para reduzir risco cardiovascular

fiercepharma.com·Aug 28, 2026 · 1 g fa

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

infobae.com·Aug 23, 2026 · 6 g fa

Panamá alerta por falsificación de un medicamento inyectable usado para tratar la diabetes tipo 2